93 related articles for article (PubMed ID: 28643552)
1. Drug-induced Physeal Abnormalities in Preclinical Toxicity Studies.
Frazier KS
Toxicol Pathol; 2017 Oct; 45(7):869-875. PubMed ID: 28643552
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ALK5 signaling induces physeal dysplasia in rats.
Frazier K; Thomas R; Scicchitano M; Mirabile R; Boyce R; Zimmerman D; Grygielko E; Nold J; DeGouville AC; Huet S; Laping N; Gellibert F
Toxicol Pathol; 2007 Feb; 35(2):284-95. PubMed ID: 17366323
[TBL] [Abstract][Full Text] [Related]
3. Effects of chemotherapy on bone metabolism and skeletal growth.
Siebler T; Shalet SM; Robson H
Horm Res; 2002; 58 Suppl 1():80-5. PubMed ID: 12373019
[TBL] [Abstract][Full Text] [Related]
4. Free physeal transplantation in the rabbit. An experimental approach to focal lesions.
Olin A; Creasman C; Shapiro F
J Bone Joint Surg Am; 1984 Jan; 66(1):7-20. PubMed ID: 6418748
[TBL] [Abstract][Full Text] [Related]
5. The thyroid hormone receptor beta-specific agonist GC-1 selectively affects the bone development of hypothyroid rats.
Freitas FR; Capelo LP; O'Shea PJ; Jorgetti V; Moriscot AS; Scanlan TS; Williams GR; Zorn TM; Gouveia CH
J Bone Miner Res; 2005 Feb; 20(2):294-304. PubMed ID: 15647824
[TBL] [Abstract][Full Text] [Related]
6. A novel tyrosine kinase inhibitor restores chondrocyte differentiation and promotes bone growth in a gain-of-function Fgfr3 mouse model.
Jonquoy A; Mugniery E; Benoist-Lasselin C; Kaci N; Le Corre L; Barbault F; Girard AL; Le Merrer Y; Busca P; Schibler L; Munnich A; Legeai-Mallet L
Hum Mol Genet; 2012 Feb; 21(4):841-51. PubMed ID: 22072392
[TBL] [Abstract][Full Text] [Related]
7. Suppression of mammalian bone growth by membrane transport inhibitors.
Loqman MY; Bush PG; Farquharson C; Hall AC
J Cell Biochem; 2013 Mar; 114(3):658-68. PubMed ID: 23059814
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone acts directly on growth plate chondrocytes to promote hypertrophic differentiation and inhibit clonal expansion and cell proliferation.
Robson H; Siebler T; Stevens DA; Shalet SM; Williams GR
Endocrinology; 2000 Oct; 141(10):3887-97. PubMed ID: 11014246
[TBL] [Abstract][Full Text] [Related]
9. Sox5 and Sox6 are needed to develop and maintain source, columnar, and hypertrophic chondrocytes in the cartilage growth plate.
Smits P; Dy P; Mitra S; Lefebvre V
J Cell Biol; 2004 Mar; 164(5):747-58. PubMed ID: 14993235
[TBL] [Abstract][Full Text] [Related]
10. Losartan increases bone mass and accelerates chondrocyte hypertrophy in developing skeleton.
Chen S; Grover M; Sibai T; Black J; Rianon N; Rajagopal A; Munivez E; Bertin T; Dawson B; Chen Y; Jiang MM; Lee B; Yang T; Bae Y
Mol Genet Metab; 2015 May; 115(1):53-60. PubMed ID: 25779879
[TBL] [Abstract][Full Text] [Related]
11. Review of the effects of anti-angiogenic compounds on the epiphyseal growth plate.
Hall AP; Westwood FR; Wadsworth PF
Toxicol Pathol; 2006; 34(2):131-47. PubMed ID: 16537292
[TBL] [Abstract][Full Text] [Related]
12. Femoral Head Growth Plate Dysplasia and Fracture in Juvenile Rabbits Induced by Off-target Antiangiogenic Treatment.
Hall AP; Mitchard T; Rolf MG; Stewart J; Duffy P
Toxicol Pathol; 2016 Aug; 44(6):866-73. PubMed ID: 27162053
[TBL] [Abstract][Full Text] [Related]
13. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation.
Gerber HP; Vu TH; Ryan AM; Kowalski J; Werb Z; Ferrara N
Nat Med; 1999 Jun; 5(6):623-8. PubMed ID: 10371499
[TBL] [Abstract][Full Text] [Related]
14. DHEA suppresses longitudinal bone growth by acting directly at growth plate through estrogen receptors.
Sun H; Zang W; Zhou B; Xu L; Wu S
Endocrinology; 2011 Apr; 152(4):1423-33. PubMed ID: 21303941
[TBL] [Abstract][Full Text] [Related]
15. Cartilage dysplasia and tissue mineralization in the rat following administration of a FGF receptor tyrosine kinase inhibitor.
Brown AP; Courtney CL; King LM; Groom SC; Graziano MJ
Toxicol Pathol; 2005; 33(4):449-55. PubMed ID: 16036862
[TBL] [Abstract][Full Text] [Related]
16. The cn/cn dwarf mouse. Histomorphometric, ultrastructural, and radiographic study in mutants corresponding to human acromesomelic dysplasia Maroteaux type (AMDM).
Shapiro F; Barone L; Johnson A; Flynn E
BMC Musculoskelet Disord; 2014 Oct; 15():347. PubMed ID: 25319082
[TBL] [Abstract][Full Text] [Related]
17. Local physeal widening on MR imaging: an incidental finding suggesting prior metaphyseal insult.
Laor T; Hartman AL; Jaramillo D
Pediatr Radiol; 1997 Aug; 27(8):654-62. PubMed ID: 9252430
[TBL] [Abstract][Full Text] [Related]
18. The perichondrium plays an important role in mediating the effects of TGF-beta1 on endochondral bone formation.
Alvarez J; Horton J; Sohn P; Serra R
Dev Dyn; 2001 Jul; 221(3):311-21. PubMed ID: 11458391
[TBL] [Abstract][Full Text] [Related]
19. Chondrocyte apoptosis enhanced at the growth plate: a physeal response to a diaphyseal fracture.
Gaber S; Fischerauer EE; Fröhlich E; Janezic G; Amerstorfer F; Weinberg AM
Cell Tissue Res; 2009 Mar; 335(3):539-49. PubMed ID: 19089454
[TBL] [Abstract][Full Text] [Related]
20. Liver X Receptor activation delays chondrocyte hypertrophy during endochondral bone growth.
Sun MM; Beier F
Osteoarthritis Cartilage; 2014 Jul; 22(7):996-1006. PubMed ID: 24852699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
